SC
SANA icon

Syon Capital’s Sana Biotechnology SANA Stock Holding History

Syon Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.6K Buy
18,501
+1,838
+11% +$5.92K ﹤0.01% 945
2026
Q1 		$48K Hold
16,663
– – ﹤0.01% 903
2025
Q4 		$67.8K Hold
16,663
– – ﹤0.01% 892
2025
Q3 		$59.2K Hold
16,663
– – ﹤0.01% 810
2025
Q2 		$45.5K Sell
16,663
-6,203
-27% -$12.8K ﹤0.01% 725
2025
Q1 		$38.4K Buy
22,866
+6,203
+37% +$17.3K ﹤0.01% 580
2024
Q4 		$27.2K Buy
+16,663
New +$49.7K ﹤0.01% 561

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Syon Capital's SANA Position: Q2 2026 in Review

Syon Capital increased its Sana Biotechnology (SANA) stake by 11% in Q2 2026, buying an estimated $5.92K and bringing the position to 18,501 shares worth $64.6K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

Syon Capital first reported a position in SANA in Q4 2024 and has held it in 7 quarters since. The position peaked at $67.8K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Syon Capital held 18,501 shares of Sana Biotechnology worth $64.6K as of Q2 2026.
  • Syon Capital bought 1,838 Sana Biotechnology shares in Q2 2026, an estimated $5.92K.
  • Sana Biotechnology made up ﹤0.01% of Syon Capital's portfolio in Q2 2026, its #945 holding.
  • Syon Capital first reported a position in Sana Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • Syon Capital's Sana Biotechnology position peaked at $67.8K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.